
==== Front
Mol Ther Nucleic Acids
Mol Ther Nucleic Acids
Molecular Therapy. Nucleic Acids
2162-2531
American Society of Gene & Cell Therapy

S2162-2531(24)00185-9
10.1016/j.omtn.2024.102298
102298
Commentary
Metabolism of tRNAs and rRNAs shape immunoactive signatures in chronic obstructive pulmonary disease and pulmonary infections
Hong Zhenyi 12
Bofill-De Ros Xavier xbofill@mbg.au.dk
12∗
1 Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
∗ Corresponding author: Xavier Bofill-De Ros, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark. xbofill@mbg.au.dk
2 These authors contributed equally

29 8 2024
10 9 2024
29 8 2024
35 3 102298© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
==== Body
pmcMain text

In two recent studies from the Kirino lab, Shigematsu et al.1 and Pawar et al.2 show that certain fragments derived from the metabolism of tRNAs and rRNAs can act as potent endogenous activators of the innate immune system (Figure 1). This novel research ventures into the role of endogenous RNA fragments as modulators of innate immunity, providing insight into Toll-like receptor (TLR) 7 biology and potential therapeutic applications.Figure 1 RNA fragments trigger immunoactive signatures in COPD and pulmonary infections via TLR7

The studies by Shigematsu et al. and Pawar et al. contribute to our understanding of how tRNA and rRNA fragments can contribute to prime the innate immune system. The authors show that 5′ tRNAValCAC and other small RNA fragments produced by cells in the context of COPD and Mycobacterium tuberculosis infection can be loaded to extracellular vesicles and stimulate the receiving macrophage by binding TLR7 in the endosomes. The illustration was created using BioRender.

TLRs are key components of the innate immune system involved in the detection of pathogen-associated and damage-associated molecular patterns. This family of receptors can be found at the cell surface or in intracellular compartments such as the endosome. They are specialized in detecting ligands such as single-stranded RNAs (TLR7 and TLR8) or double-stranded RNAs (TLR3), which are usually associated with infection by pathogens but can also arise from endogenous cellular origins.3,4 Extracellular vesicles released from cells can be uptaken by macrophages and T and B cells and release their cargo into endosomes.5 Upon activation in the endosome, TLR7 promotes the transcription and induction of interferon and cytokines via the signaling cascade initiated by MyD88.

In these recent publications, the authors find that patients with chronic obstructive pulmonary disease (COPD) and pulmonary infections such as Mycobacterium tuberculosis present a distinct composition in tRNA and rRNA fragments when compared to healthy controls. To this end, the authors use a modified protocol for the preparation of next-generation sequencing libraries that consists of treatment with T4 polynucleotide kinase (PNK). This additional step, compared to traditional methods for cloning small RNAs such as microRNAs, allows the generation of 5′ phosphate and 3′ hydroxyl ends that are suitable for the adapter ligation and subsequent detection. Using this approach, the authors report that patients with COPD have an overexpression of 5′ tRNAValCAC and a reduction of 5′ tRNAGlyGCC. The same 5′ tRNAValCAC fragment was also found upregulated when human monocyte-derived macrophages were exposed to lipopolysaccharides and in the plasma of patients infected with Mycobacterium tuberculosis. This evidence indicates a role of 5′ tRNAValCAC as a maker of pulmonary inflammation. Similarly, the authors identified two ribosomal fragments derived from the 18S and 28S subunits differentially expressed in patients with COPD (18S-np22 and 28S-np4533, respectively).

Interestingly, functional studies of the role of fragment 5′ tRNAValCAC and rRNAs loaded into extracellular vesicles indicate their role as potent inducers of inflammatory cytokines such as tumor necrosis factor alpha, interleukin (IL)-1β, IL-12p40, and IL-6. The authors show that upon knockout of TLR7, the immunostimulatory activity of the identified tRNA and rRNA fragments is lost. In addition, this stimulation by tRNA and rRNA fragments provides derived macrophages with an increased capacity to eliminate bacteria in a cell-based assay.

In-depth molecular studies of 5′ tRNAValCAC and 5′ tRNAHisGUG, previously reported,6 indicate that the recognition of endogenous immunostimulant single-stranded RNAs by TLR7 is very specific. Through a series of mutagenesis studies, the authors identify that a terminal GUUU motif (or UUUG) is required for TLR7 activation. The authors note that even though both 5′ tRNAValCAC and 5′ tRNAHisGUG retain a certain secondary structure, the identified GUUU motif is found in a terminal region on a single strand. This mechanism of recognition by TLR7 via the terminal GUUU motif appears to be conserved with other immunoregulatory RNAs such as miR-122-5p, miR-552-5p, or miR-548ah-5p. All of them when studied systematically presented similar 3-fold upregulation of inflammatory cytokines. Finally, the authors found that the GUUU motif can also activate TLR7-related cytokines when presented in the context of synthetic oligonucleotide sequences, thus indicating a robust recognition of such motifs. Lastly, the analysis of the effects of RNA modifications frequently found on tRNAs, such as pseudouridine and 2-methylguanosine, indicates that they can, to a moderate extent, affect the immunoregulatory role of 5′ tRNAValCAC.

These two compelling studies from the Kirino lab also point to important questions for the field. It will be interesting to see how future studies address the role of the different enzymes involved in RNA metabolism in the formation of these immune regulators from endogenous RNA species, in particular whether angiogenin or other ribonucleases are responsible for the formation of tRNA halves upon COPD or other infectious or inflammatory processes. In this line, angiogenin was previously identified to generate stress-specific tRNA halves of specific tRNAs,7 including, among others, 5′ tRNAValCAC. Other interesting aspects of the regulation of these immunoactive RNA species could be whether RNA ligases known to repair “nicked tRNAs” could play a role in regulating the production and release of these RNA fragments into biofluids.8,9

Overall, Shigematsu et al.1 and Pawar et al.2 show the role of specific tRNAs and rRNAs as biomarkers and immunoactive signatures. By leveraging novel library preparation methods, the authors exemplify the importance of incorporating cutting-edge methods for the detection of novel biomarkers in biologically relevant samples. The mechanistic work indicates that the activity of 5′ tRNAValCAC in macrophages has major effects by triggering the activity of TLR7. The in-depth mechanisms of biogenesis and export of these immunoactive products, as well as its effects in the context of living organisms, remain to be studied. Nevertheless, the authors presented a compelling case supporting the role of tRNA and rRNA fragments in the lungs of patients with COPD and bacterial infections.

Acknowledgments

Research in our laboratory is supported by the 10.13039/501100003554 Lundbeck Foundation (R368-2021-428 ), 10.13039/501100010344 Aage og Johanne Louis-Hansens Fond (J.nr.23-2B-14365 ), and 10.13039/501100006309 Riisfort Fonden .

Author contributions

Z.H. and X.B.-D.R. have conceived and written this commentary.

Declaration of interests

X.B.-D.R. is a member of the editorial board and a section editor for Molecular Therapy Nucleic Acids. X.B.-D.R. is a consultant for MarPam Pharma and Iris Medicine.
==== Refs
References

1 Shigematsu M. Kawamura T. Deshpande D.A. Kirino Y. Immunoactive signatures of circulating tRNA- and rRNA-derived RNAs in chronic obstructive pulmonary disease Mol. Ther. Nucleic Acids 35 2024 102285 10.1016/j.omtn.2024.102285
2 Pawar K. Kawamura T. Kirino Y. The tRNAVal half: A strong endogenous Toll-like receptor 7 ligand with a 5’-terminal universal sequence signature Proc. Natl. Acad. Sci. USA 121 2024 e2319569121
3 Chen Y.G. Hur S. Cellular origins of dsRNA, their recognition and consequences Nat. Rev. Mol. Cell Biol. 23 2022 286 301 34815573
4 Roers A. Hiller B. Hornung V. Recognition of endogenous nucleic acids by the innate immune system Immunity 44 2016 739 754 27096317
5 Buzas E.I. The roles of extracellular vesicles in the immune system Nat. Rev. Immunol. 23 2023 236 250 35927511
6 Pawar K. Shigematsu M. Sharbati S. Kirino Y. Infection-induced 5’-half molecules of tRNAHisGUG activate Toll-like receptor 7 PLoS Biol. 18 2020 e3000982
7 Su Z. Kuscu C. Malik A. Shibata E. Dutta A. Angiogenin generates specific stress-induced tRNA halves and is not involved in tRF-3-mediated gene silencing J. Biol. Chem. 294 2019 16930 16941 31582561
8 Chen X. Wolin S.L. Transfer RNA halves are found as nicked tRNAs in cells: evidence that nicked tRNAs regulate expression of an RNA repair operon RNA 29 2023 620 629 36781286
9 Costa B. Li Calzi M. Castellano M. Blanco V. Cuevasanta E. Litvan I. Ivanov P. Witwer K. Cayota A. Tosar J.P. Nicked tRNAs are stable reservoirs of tRNA halves in cells and biofluids Proc. Natl. Acad. Sci. USA 120 2023 e2216330120
